Clinical trial

To Evaluate the Effect of MCS® in Prostate Cancer Prevention

NCT02042807

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-10-01

PhasePHASE2

Study timeline

Study start (unknown)2014-10-01Date precision: month

Registry last updated2024-06-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

PlaceboDRUG

MCS®DRUG

Sponsors & collaborators

Health Ever Bio-Tech Co., Ltd.lead sponsor

Mapped research locations

TaipeiTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02042807 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.